Abstract
Discovering safe, novel immunomodulators that are effective in RA is currently a major therapeutic objective. Long-term immune system deviation is most striking in the host-parasite relationship, in which microbes may coexist with a human host. ES-62 exhibited powerful immunomodulation of CIA, preventing initiation of inflammatory arthritis. Crucially, ES-62 suppressed even established disease. These effects were due to inhibition of cytokine release, specifically TNF-α, and reversal of collagen specific Th1 responses associated with reduced expression of IFN-γ. The physiologic relevance of these observations was confirmed, as ES-62 down-regulated the release of proinflammatory cytokines (TNF-α and IL-6) from patient-derived samples.
Original language | English |
---|---|
Pages (from-to) | 52-52 |
Number of pages | 1 |
Journal | Arthritis Research and Therapy |
Volume | 5 |
Issue number | Suppl 1 |
DOIs | |
Publication status | Published - 24 Feb 2003 |
Event | 23rd European Workshop for Rheumatology Research - Marseille, France Duration: 27 Mar 2003 → … |
Keywords
- cytokine modulation
- physiology
- immunology
- articular inflammation